Specimen SS-F-UMA-283 // UMAMI · IFI-U
Nucleotide Synergy I-BL-A
Glycine max
Soybean
Target Trait
2×
fold-change
IMP + GMP combined nucleotide synergy score
Technical Specifications
SKU
SS-F-UMA-283
Genomic Edits
5
GC Content
46.3-52.3%
Construct Length
3,142 bp
Promoter System
CaMV 35S / Ubiquitin
Expression System
Biolistic particle bombardment
Host Strain
Particle Gun
Receptor Target
mGluR1 / TAS1R1-TAS1R3
IFI Score
200
Pathway Edits
- GmADSS adenylosuccinate synthase overexpression for elevated IMP via de-novo purine pathway in Glycine max seed tissue
- GmIMPDH2 inosine monophosphate dehydrogenase balanced overexpression for IMP/GMP co-accumulation without net IMP depletion
- GmGMPS GMP synthase activity tuned to 60% of IMPDH output to maintain 1.7:1 IMP:GMP ratio for maximum synergy
- GmADSL adenylosuccinate lyase upregulation ensuring AMP/IMP cycling prevents adenylate deficiency during IMP accumulation phase
- GmNT5C 5′-nucleotidase expression calibrated via synthetic promoter strength to maintain free nucleotide fraction over phosphorylated forms
Key Interventions
IFI Subscale Profile
IFI Profile
Use Case
Soy-based umami concentrates, plant-based meat flavor systems, and fermented tofu products where dual-nucleotide synergy delivers maximum umami without exogenous additives. Ideal for functional food ingredient manufacturers.
License
$299 · Tier I License
Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.
Already purchased?